Literature DB >> 29088467

Anti-Programmed Cell Death Protein-1 Immunotherapy for Glioblastoma is Impaired by Systemic Chemotherapy but Enhanced in Combination With Locally Delivered Chemotherapy.

Nathan A Ehrlich1, Ray R Zhang1, John S Kuo1.   

Abstract

Entities:  

Year:  2017        PMID： 29088467      PMCID： PMC6257033          DOI： 10.1093/neuros/nyx453

Source DB:  PubMed          Journal:  Neurosurgery        ISSN： 0148-396X            Impact factor:   4.654


× No keyword cloud information.
  1 in total

1.  Anti-PD-1 antitumor immunity is enhanced by local and abrogated by systemic chemotherapy in GBM.

Authors:  Dimitrios Mathios; Jennifer E Kim; Antonella Mangraviti; Jillian Phallen; Chul-Kee Park; Christopher M Jackson; Tomas Garzon-Muvdi; Eileen Kim; Debebe Theodros; Magdalena Polanczyk; Allison M Martin; Ian Suk; Xiaobu Ye; Betty Tyler; Chetan Bettegowda; Henry Brem; Drew M Pardoll; Michael Lim
Journal:  Sci Transl Med       Date:  2016-12-21       Impact factor: 17.956
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.